Seroprevalence of markers for hepatitis B, C and G in male and female prisoners - NSW, 1996

Australian and New Zealand Journal of Public Health

Volumn 23, Issue 4, 1999, Pages 377-384

  Butler, Tony ^a   Spencer, Jenean ^b   Cui, Jisheng ^b   Vickery, Karen ^b   Zou, Jean ^b   Kaldor, John ^b  

^a New South Wales Government   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS ANTIBODY; HEPATITIS B CORE ANTIBODY;

ABORIGINE; ADULT; AGED; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; INSTITUTIONALIZATION; INTRAVENOUS DRUG ABUSE; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRISONER; RISK FACTOR; SELF REPORT; SEROPREVALENCE; SUPERINFECTION;

EID: 0032787756     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1999.tb01278.x     Document Type: Article

References (33)

1. Butler T, Dolan K, Ferson M, et al. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 1997; 166: 127.
2. Crofts N, Stewart T, Hearne P. Spread of blood borne viruses among Australian prison entrants Br Med J 1996; 310: 285-8.
3. National Centre in HIV Epidemiology and Clinical Research (editor). HIV/AIDS And Related Diseases In Australia. Annual Surveillance Report. National Centre in HIV Epidemiology and Clinical Research, University of NSW, 1997.
4. Ford P, White C, Kaufmann H, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. Can Med Assoc J 1995; 153: 1605-9.
5. Malliori M, Syspa V, Psichogiou M, et al. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction 1998; 93: 243-51.
6. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-9.
7. Butler T. Preliminary Findings Of The NSW Inmates' Health Survey. Sydney: NSW Corrections Health Service, 1997.
8. Casas I, Powell L, Klapper PE, et al. New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 1995; 53: 25-36.
9. Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271(5248): 505-8.
10. STATA [statistical software]. Release 5.0. College Station (TX): STATA Corporation, 1997.
11. Hepatitis Viruses. Lyon (France): World Health Organisation, 1994. IARC Monographs on the evaluation of carcinogenic risks to humans, Volume No.: 59.
12. Hurlen B, Siebke J, Stensland A. Viral hepatitis among prisoners in Norway. NIPH Annals 1980; 3: 129-32.
13. Prefontaine R, Chaundry RK. Seroepidemiologic Study of Hepatitis B and C viruses in Federal Correctional Institutions in British Columbia. Can Dis Wkly Rep 1990; 16-52: 415-6.
14. Vlahov D, Nelson KE, Quinn TC, et al. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9: 566-9.
15. Koplan JP, Walker JA, Bryan JA. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis 1978; 137: 505.
16. Decker MD, Vaughn WK, Brodie JS, et al. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis 1984; 150: 450-8.
17. Anon C, del-Olmo J, Llovet F, et al. The hepatitis C virus among the prison population of Valencia. Rev Esp Enferm Dig 1995; 87: 505-8.
18. Chamot E, de Saussure P, Hirschel B, et al. Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS 1992; 6: 430-1.
19. Hull HF, Lyons LH, Mann JM, et al. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health 1985; 75: 1213-4.
20. Melico-Silvestre A, Pombo V, Pereira A, et al. Seroepidemiological survey of transmissible infections in Portuguese prisoners. AIDS 1991; 5: 780-1.
21. Barry MA, Gleavy D, Herd K, et al. Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction. Am J Public Health 1990; 80: 471-3.
22. Acedo A, Campos A, Bauza J, et al. HIV infection, hepatitis, and syphilis in Spanish prisons. Lancet 1989; July: 226.
23. Stark K, Bienzle U, Hess G, et al. Detection of hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-3.
24. Moaven L, Hyland C, Young I, et al. Prevalence of hepatitis G virus in Queensland blood donors. Med J Aust 1996; 165: 369-71.
25. Thomas DL, Nakatsuji Y, Shih JW, et al. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 1997; 176, 586-92.
26. Kew M, Kassianides C. HGV: Hepatitis G virus or harmless G virus. Lancet 1996; 348: 10.
27. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Prevalence of GB virus type C hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: Evidence of sexual and parenteral transmission. Transfusion 1999; 39: 83-94.
28. Britton WJ, Parsons C, Gallagher ND, et al. Risk factors associated with hepatitis B infection in antenatal patients. Aust N Z J Med 1985; 15: 641-4.
29. Burrell CJ, Cameron AS, Hart G, et al. Hepatitis B reservoirs and attack rates in an Australian community: A basis for vaccination and cross infection policies. Med J Aust 1983 2: 492-6.
30. Eyland S. Aboriginal And Torres Strait Islander Inmates. Facts And Figures. Sydney: NSW Department of Corrective Services, 1996 November. Statistical Publication No.: 15
31. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-4.
32. Bayas J, Bruguera M, Martin V, et al. Hepatitis B vaccination in prisons: The Catalonian experience. Vaccine 1993; 11: 1441-4.
33. Chevalleau G, Rotily M. Cost-effectiveness of hepatitis B immunisation programmes in prison. Second European Seminar On HIV And Hepatitis In Prison: 1997 December; Bonn, Germany.